<DOC>
	<DOC>NCT02504606</DOC>
	<brief_summary>This clinical trial was evaluated to compare the safety and pharmacokinetics of Besylsartan with Amosartan, which was available commercially after single oral dose in healthy male subjects.</brief_summary>
	<brief_title>Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject</brief_title>
	<detailed_description />
	<mesh_term>Losartan</mesh_term>
	<criteria>Body Mass Index (BMI) between 18 and 30 Healthy as determined by a responsible physician History of clinically significant disease Any chronic disease Creatine clearance less than 50ml/min Hypotension (100mmHg/60mmHg) Treatment of barbital type drug within 1 month Administration of herbal medicine within 7 days</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>